Published in World J Surg Oncol on July 05, 2007
Breast metastasis from renal cell carcinoma: rare initial presentation of disease recurrence after 5 years. J Breast Cancer (2012) 0.89
Breast Metastasis from Medullary Thyroid Carcinoma in a Male Patient: Case Report and Review of the Literature. Rare Tumors (2015) 0.79
Non-epithelial malignancies and metastatic tumours of the breast. Ulster Med J (2009) 0.78
Fine-needle aspiration of metastatic renal cell carcinoma to a male breast: A rare initial presentation. Cytojournal (2014) 0.75
Rare Malignant Tumors of the Breast. J Clin Imaging Sci (2015) 0.75
Metachronous isolated breast metastasis from pulmonary adenocarcinoma with micropapillary component causing diagnostic challenges. BMC Cancer (2014) 0.75
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med (2001) 11.73
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg (2004) 6.75
A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep (1980) 4.66
Cancers metastatic to the breast. Cancer (1972) 2.83
Carcinoid tumor metastatic to the breast. Arch Surg (1998) 2.71
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol (2006) 2.69
Secondary neoplasms of the breast: a survey of the 20th Century. Cancer (2001) 2.07
Metastases to the breast from extramammary neoplasms. A report of six cases with diagnosis by fine needle aspiration cytology. Acta Cytol (1997) 2.07
Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg (2003) 2.06
Metastatic disease to the breast: clinical, pathologic, and radiographic features. AJR Am J Roentgenol (1977) 1.84
Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg (2000) 1.73
Breast metastases from extramammary malignancies. Radiology (1982) 1.51
Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery (2004) 1.30
Metastasis to the breast. Radiol Clin North Am (1982) 1.26
Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg (2001) 1.14
Current approaches to medullary thyroid carcinoma, sporadic and familial. J Surg Oncol (2006) 1.11
Metastases to breast simulating ductal carcinoma in situ: report of two cases and review of the literature. Ann Diagn Pathol (2001) 1.11
Intensive surgical and chemotherapeutic management of advanced ovarian cancer. Surg Clin North Am (1978) 1.10
Malignant melanoma metastatic to the breast: a report of seven cases diagnosed by fine-needle aspiration cytology. Cancer (1998) 1.06
Secondary deposits in the breast. Br J Cancer (1965) 0.93
Cytoreductive surgery for advanced stages of ovarian cancer. Semin Surg Oncol (2000) 0.92
Palliative surgery for gastric cancer. Cancer (1988) 0.88
Metastasis to the breast: a rare site for secondary malignancy. Int J Surg (2005) 0.86
The effect of residual mass size on response to chemotherapy after surgical cytoreduction for advanced ovarian cancer: long-term results. Int J Gynecol Cancer (2002) 0.83
Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid (2009) 10.20
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol (2002) 6.60
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer. J Clin Oncol (2010) 2.96
EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res (2004) 2.78
Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med (2005) 2.73
Noninvasive photoacoustic identification of sentinel lymph nodes containing methylene blue in vivo in a rat model. J Biomed Opt (2008) 2.65
Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical Oncology. Ann Surg Oncol (2007) 2.50
Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data. Ann Surg Oncol (2007) 2.36
Sentinel lymph nodes in the rat: noninvasive photoacoustic and US imaging with a clinical US system. Radiology (2010) 2.35
Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J Biol Chem (2004) 2.18
Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg (2009) 2.14
Sentinel lymph node biopsy in patients with thin melanoma. Arch Dermatol (2003) 2.11
US breast cancer mortality trends in young women according to race. Cancer (2014) 2.07
Neuroendocrine tumors. J Natl Compr Canc Netw (2012) 1.91
Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am J Physiol Endocrinol Metab (2002) 1.82
Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J Immunol (2009) 1.75
Inhibition of medullary thyroid carcinoma cell proliferation and RET phosphorylation by tyrosine kinase inhibitors. Surgery (2002) 1.70
Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis. Clin Cancer Res (2013) 1.67
Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol (2007) 1.66
Risk factors for surgical site infection after major breast operation. J Am Coll Surg (2008) 1.66
Handheld array-based photoacoustic probe for guiding needle biopsy of sentinel lymph nodes. J Biomed Opt (2010) 1.65
Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapy. Am J Surg (2007) 1.65
Pheochromocytoma penetrance varies by RET mutation in MEN 2A. Surgery (2007) 1.64
Hospital-associated costs due to surgical site infection after breast surgery. Arch Surg (2008) 1.62
Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis. World J Surg (2010) 1.57
Changes in sexual problems over time in women with and without early-stage breast cancer. Menopause (2010) 1.56
Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth. Cancer Immunol Immunother (2012) 1.55
Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data. Ann Surg Oncol (2008) 1.55
Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors. J Surg Res (2012) 1.53
Predictors of primary breast abscesses and recurrence. World J Surg (2009) 1.51
Neuroendocrine tumors, version 1.2015. J Natl Compr Canc Netw (2015) 1.51
Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis. Ann Surg (2014) 1.50
Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models. J Clin Invest (2012) 1.49
A tat fusion protein-based tumor vaccine for breast cancer. Ann Surg Oncol (2005) 1.47
Perioperative outcomes and complications of laparoscopic ventral hernia repair. Surgery (2005) 1.45
Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients. Clin Cancer Res (2007) 1.45
Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells. J Immunother (2007) 1.45
Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence. Mol Cancer Res (2011) 1.42
ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol (2006) 1.41
Predictors of axillary lymph node involvement in women with T3 breast cancers: analysis of 1988-2003 SEER data. J Surg Res (2009) 1.39
Biochemical cure after reoperations for medullary thyroid carcinoma: a meta-analysis. Ann Surg Oncol (2014) 1.39
Residual nodal disease in biopsy proven n1/n2 breast cancer following neoadjuvant systemic therapy. World J Surg (2010) 1.37
Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cells. J Immunol (2002) 1.37
IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity. J Clin Invest (2013) 1.36
Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study. Dis Colon Rectum (2008) 1.35
Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer. J Immunol (2010) 1.35
2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism. Cancer Res (2003) 1.34
Transfer of TCR genes into mature T cells is accompanied by the maintenance of parental T cell avidity. J Immunol (2003) 1.32
Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion. Cancer Res (2009) 1.30
The role of poverty rate and racial distribution in the geographic clustering of breast cancer survival among older women: a geographic and multilevel analysis. Am J Epidemiol (2008) 1.28
Patient and tumor characteristics associated with increased mortality in young women (< or =40 years) with breast cancer. J Surg Oncol (2009) 1.27
Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit. Cancer Discov (2014) 1.26
Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma. J Immunother (2006) 1.26
Disparities related to socioeconomic status and access to medical care remain in the United States among women who never had a mammogram. Cancer Causes Control (2003) 1.24
Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer. J Immunother (2009) 1.23
Defining the antigen-specific T-cell response to vaccination and poly(I:C)/TLR3 signaling: evidence of enhanced primary and memory CD8 T-cell responses and antitumor immunity. J Immunother (2005) 1.22
An innovative microarray strategy identities informative molecular markers for the detection of micrometastatic breast cancer. Clin Cancer Res (2005) 1.21
Photoacoustic microscopy of tyrosinase reporter gene in vivo. J Biomed Opt (2011) 1.21
Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected]. J Mol Diagn (2003) 1.20
Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients. Breast Cancer Res Treat (2004) 1.19
Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection. J Immunol (2010) 1.18
Predictors of complete pathological response after neoadjuvant systemic therapy for breast cancer. Am J Surg (2009) 1.16
Down-regulation of sphingosine kinase-1 by DNA damage: dependence on proteases and p53. J Biol Chem (2004) 1.15
Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice. Ann Surg Oncol (2006) 1.15
Needle biopsy of incidentally discovered adrenal masses is rarely informative and potentially hazardous. Surgery (2007) 1.13
Gastrointestinal manifestations of multiple endocrine neoplasia type 2. Ann Surg (2002) 1.12
Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration. Int J Cancer (2007) 1.12
Current approaches to medullary thyroid carcinoma, sporadic and familial. J Surg Oncol (2006) 1.11
Geographic clustering of adequate diagnostic follow-up after abnormal screening results for breast cancer among low-income women in Missouri. Ann Epidemiol (2007) 1.10
Racial disparities in breast cancer survival: an analysis by age and stage. J Surg Res (2008) 1.09
Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration. Ann Surg Oncol (2010) 1.08
Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer. Clin Cancer Res (2009) 1.08
Treatment and outcomes of patients with primary breast sarcoma. Am J Surg (2008) 1.07
Surveillance mammography and the risk of death among elderly breast cancer patients. Breast Cancer Res Treat (2007) 1.07
Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape. Cancer (2002) 1.07